🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. logo
Market Cap: Low
Employees: Low

PB272 (neratinib, oral)

Puma Biotechnology, Inc. focuses on the development and commercialization of products to enhance cancer care, with drug candidates including PB272 neratinib for various stages and types of cancer, and has various license agreements for its product distribution.

Tags: HER2-positive, biopharmaceutical, breast cancer, cancer care, drug development, solid tumors

Website

About | Leadership | About | About | Contact | Contact

Symbol: PBYI

Recent Price: $3.13

Industry: Biotechnology

CEO: Mr. Alan H. Auerbach

Sector: Healthcare

Employees: 185

Address: 10880 Wilshire Boulevard, Los Angeles, CA 90024

Phone: 424 248 6500

Leadership

  • Alan H. Auerbach, President and Chairman of the Board
  • Maximo F. Nougues, Chief Financial Officer
  • Jeff J. Ludwig, Chief Commercial Officer
  • Douglas Hunt, B.Sc (Hons), Senior Vice President, Regulatory Affairs, Pharmacovigilance, Medical Affairs and Law

Last updated: 2024-12-31